Protective Effects of Nobiletin Against Endotoxic Shock in Mice Through Inhibiting TNF-α, IL-6, and HMGB1 and Regulating NF-κB Pathway

Inflammation

Volumn 39, Issue 2, 2016, Pages 786-797

  Li, Weifeng ^a   Wang, Xiumei ^a   Niu, Xiaofeng ^a   Zhang, Hailin ^a   He, Zehong ^a   Wang, Yu ^a   Zhi, Wenbing ^a   Liu, Fang ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

endotoxic shock; NF B; nobiletin; pro inflammatory cytokine

Indexed keywords

ENDOTOXIN; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NOBILETIN; TUMOR NECROSIS FACTOR ALPHA; FLAVONE DERIVATIVE; HMGB1 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXPERIMENTAL SEPTIC SHOCK; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INFLAMMATORY CELL; LIVER NECROSIS; MALE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SURVIVAL RATE; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; IMMUNOLOGY; KIDNEY; LIVER; LUNG; MACROPHAGE; METABOLISM; PATHOLOGY; SHOCK, SEPTIC;

ANIMALS; FLAVONES; HMGB1 PROTEIN; INTERLEUKIN-6; KIDNEY; LIPOPOLYSACCHARIDES; LIVER; LUNG; MACROPHAGES; MALE; MICE; NF-KAPPA B; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84957601598     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-016-0307-5     Document Type: Article

References (41)

1. Karima, R., S. Matsumoto, H. Higashi, and K. Matsushima. 1999. The molecular pathogenesis of endotoxic shock and organ failure. Molecular Medicine Today 5: 123–132.
2. Bone, R.C., C.J. Grodzin, and R.A. Balk. 1997. Sepsis: a new hypothesis for pathogenesis of the disease process. CHEST Journal 112: 235–243.
3. Angus, D.C., W.T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M.R. Pinsky. 2001. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Critical Care Medicine 29: 1303–1310.
4. Yan, Y., H. Zhou, H. Gao, L. Chen, L. Chen, L. Gao, et al. 2013. Endogenous hydrogen sulfide formation mediates the liver damage in endotoxemic rats. Research in Veterinary Science 94: 590–595.
5. Moss, M. 2005. Epidemiology of sepsis: race, sex, and chronic alcohol abuse. Clinical Infectious Diseases 41: S490–S497.
6. Marshall, J.C. 2003. Such stuff as dreams are made on: mediator-directed therapy in sepsis. Nature Reviews Drug Discovery 2: 391–405.
7. Paterson, R., and N. Webster. 2000. Sepsis and the systemic inflammatory response syndrome. Journal of the Royal College of Surgeons of Edinburgh 45: 178–182.
8. Lappin, E., and A.J. Ferguson. 2009. Gram-positive toxic shock syndromes. The Lancet infectious diseases 9: 281–290.
9. Lin, Q., L. Jin, Z. Cao, H. Li, and Y. Xu. 2008. Protective effect of Acanthopanax senticosus extract against endotoxic shock in mice. Journal of Ethnopharmacology 118: 495–502.
10. Leeman, J.R., and T.D. Gilmore. 2008. Alternative splicing in the NF-κB signaling pathway. Gene 423: 97–107.
11. Liu, L., Q. Mu, W. Li, W. Xing, H. Zhang, T. Fan, et al. 2015. Isofraxidin protects mice from LPS challenge by inhibiting pro-inflammatory cytokines and alleviating histopathological changes. Immunobiology 220: 406–413.
12. Mei, X., D. Xu, S. Xu, Y. Zheng, and S. Xu. 2012. Novel role of Zn (II)-curcumin in enhancing cell proliferation and adjusting proinflammatory cytokine-mediated oxidative damage of ethanol-induced acute gastric ulcers. Chemico-Biological Interactions 197: 31–39.
13. Kishimote, T., S. Akira, and T. Taga. 1992. Interleukln-6 and Its Receptor: a paradigm for cytoklnes. Science 258: 593–597.
14. Li, S., H. Bao, L. Han, and L. Liu. 2010. Effects of propofol on early and late cytokines in lipopolysaccharide-induced septic shock in rats. Journal of biomedical research 24: 389–394.
15. Sun, N., and C. Chao. 2005. The cytokine activity of HMGB1-extracellular escape of the nuclear protein. Chang Gung Medical Journal 28: 673.
16. Alves, J.N., K.M.P. Pires, M. Lanzetti, M.V. Barroso, C.F. Benjamim, C.A. Costa, et al. 2013. Critical role for CCR2 and HMGB1 in induction of experimental endotoxic shock. Archives of Biochemistry and Biophysics 537: 72–81.
17. Asavarut, P., H. Zhao, J. Gu, and D. Ma. 2013. The role of HMGB1 in inflammation-mediated organ injury. Acta Anaesthesiologica Taiwanica 51: 28–33.
18. Feng, Y., Q. Yang, J. Xu, G. Qian, and Y. Liu. 2008. Effects of HMGB1 on PMN apoptosis during LPS-induced acute lung injury. Experimental and Molecular Pathology 85: 214–222.
19. Lappas, M., M. Permezel, H.M. Georgiou, and G.E. Rice. 2002. Nuclear factor kappa B regulation of proinflammatory cytokines in human gestational tissues in vitro. Biology of Reproduction 67: 668–673.
20. O’Sullivan, A.W., J.H. Wang, and H.P. Redmond. 2009. NF-κB and P38 MAPK inhibition improve survival in endotoxin shock and in a cecal ligation and puncture model of sepsis in combination with antibiotic therapy. Journal of Surgical Research 152: 46–53.
21. Hayden, M.S., and S. Ghosh. 2008. Shared principles in NF-κB signaling. Cell 132: 344–362.
22. De Stefano, D., M.C. Maiuri, B. Iovine, A. Ialenti, M.A. Bevilacqua, and R. Carnuccio. 2006. The role of NF-κB, IRF-1, and STAT-1α transcription factors in the iNOS gene induction by gliadin and IFN-γ in RAW 264.7 macrophages. Journal of Molecular Medicine 84: 65–74.
23. Rim, H.K., C.H. Yun, J.S. Shin, Y.W. Cho, D.S. Jang, J.H. Ryu, et al. 2013. 5, 6, 7-Trimethoxyflavone suppresses pro-inflammatory mediators in lipopolysaccharide-induced RAW 264.7 macrophages and protects mice from lethal endotoxin shock. Food and Chemical Toxicology 62: 847–855.
24. Ghosh, S., and M.S. Hayden. 2008. New regulators of NF-κB in inflammation. Nature Reviews Immunology 8: 837–848.
25. Liu, S.F., and A.B. Malik. 2006. NF-κB activation as a pathological mechanism of septic shock and inflammation. American Journal of Physiology-Lung Cellular and Molecular Physiology 290: L622–L645.
26. Pande, V., and M. Ramos. 2005. NF-κB in human disease: current inhibitors and prospects for de novo structure based design of inhibitors. Current Medicinal Chemistry 12: 357–374.
27. Nogata, Y., K. Sakamoto, H. Shiratsuchi, T. Ishii, M. Yano, and H. Ohta. 2006. Flavonoid composition of fruit tissues of citrus species. Bioscience, Biotechnology, and Biochemistry 70: 178–192.
28. Choi, S., H. Ko, S. Ko, J. Hwang, J. Park, S. Kang, et al. 2007. Correlation between flavonoid content and the NO production inhibitory activity of peel extracts from various citrus fruits. Biological and Pharmaceutical Bulletin 30: 772–778.
29. Murakami, A., T. Shigemori, and H. Ohigashi. 2005. Zingiberaceous and citrus constituents, 1’-acetoxychavicol acetate, zerumbone, auraptene, and nobiletin, suppress lipopolysaccharide-induced cyclooxygenase-2 expression in RAW264. 7 murine macrophages through different modes of action. The Journal of nutrition 135: 2987S–2992S.
30. Wu, Y., C. Zhou, J. Tao, and S. Li. 2006. Antagonistic effects of nobiletin, a polymethoxyflavonoid, on eosinophilic airway inflammation of asthmatic rats and relevant mechanisms. Life Sciences 78: 2689–2696.
31. Li, Y., L. Gan, G.Q. Li, L. Deng, X. Zhang, and Y. Deng. 2014. Pharmacokinetics of plantamajoside and acteoside from Plantago asiatica in rats by liquid chromatography–mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 89: 251–256.
32. Wang, H., O. Bloom, M. Zhang, J.M. Vishnubhakat, M. Ombrellino, J. Che, et al. 1999. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248–251.
33. Silva, A.T., K.F. Bayston, and J. Cohen. 1990. Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor- in experimental gram-negative shock. Journal of Infectious Diseases 162: 421–427.
34. Ohlsson, K., P. Björk, M. Bergenfeldt, R. Hageman, and R.C. Thompson. 1990. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 348: 550–552.
35. Roth, R.I., D. Su, A.H. Child, N.R. Wainwright, and J. Levin. 1998. Limulus antilipopolysaccharide factor prevents mortality late in the course of endotoxemia. Journal of Infectious Diseases 177: 388–394.
36. Adib-Conquy, M., and J.M. Cavaillon. 2007. Stress molecules in sepsis and systemic inflammatory response syndrome. FEBS Letters 581: 3723–3733.
37. Chen, F., V. Castranova, X. Shi, and L.M. Demers. 1999. New insights into the role of nuclear factor-κB, a ubiquitous transcription factor in the initiation of diseases. Clinical Chemistry 45: 7–17.
38. Tseng, T., M. Chen, M. Tsai, Y. Hsu, C. Chen, and T.J. Lee. 2012. Oroxylin-A rescues LPS-induced acute lung injury via regulation of NF-κB signaling pathway in rodents.
39. Sun, J., G. Chi, L.W. Soromou, N. Chen, M. Guan, Q. Wu, et al. 2012. Preventive effect of imperatorin on acute lung injury induced by lipopolysaccharide in mice. International Immunopharmacology 14: 369–374.
40. Meisner, M., J. Schmidt, M. Schywalsky, and K. Tschaikowsky. 2000. Influence of pyrrolidine dithiocarbamate on the inflammatory response in macrophages and mouse endotoxin shock. International Journal of Immunopharmacology 22: 83–90.
41. Wang, M., T. Liu, D. Wang, Y. Zheng, X. Wang, and J. He. 2011. Therapeutic effects of pyrrolidine dithiocarbamate on acute lung injury in rabbits. Journal of Translational Medicine 9: 61.